XI\'AN,China,Aug. 27,2024-- Entrepreneur Universe Bright Group ("EUBG" or the "Company") (OTCQB: EUBG),a digital marketing consulting company,is pleased to announce today that its
Aug 28, 2024
HONG KONG,Aug. 27,2024-- On August 22,AAC Technologies (02018.HK) held its 2024 interim results presentation in Hong Kong,delivering remarkably impressive performance.
Aug 28, 2024
INDIANAPOLIS and PARIS,Aug. 27,2024-- Stamus Networks,a global provider of high-performance network-based threat detection and response (NDR) systems,today announced it has been named a Sample Vendor
Aug 28, 2024
BRENTWOOD,Tenn.,Aug. 27,2024--Currax Pharmaceuticals LLC ("Currax") today announced the results of a Cardiovascular Health Outcomes Analysis (HOA). The results showed there is no evidence o
Aug 28, 2024
NANPING,China,Aug. 27,2024-- Golden Heaven Group Holdings Ltd. ("Golden Heaven" or the "Company") (Nasdaq: GDHG),an amusement park operator inChina,today announced that it was gran
Aug 28, 2024
Partnership Aims to Increase Satisfaction,Loyalty,and Retention Rates of Pluxee Cardholders SÃO PAULO,Aug. 27,2024--DXC Technology (NYSE:DXC),a leading Fortune 500 global technology services pr
Aug 28, 2024
BEIJING,Aug. 27,2024-- A news report from Beijing Review: In 1776,Scottish philosopher and economist Adam Smith published An Inquiry Into the Nature and Causes of the Wealth of Nations. In it,he put f
Aug 28, 2024
SHANGHAI,Aug. 27,2024-- Xiao-I Corporation ("Xiao-I" or the "Company") (NASDAQ: AIXI),a leading artificial intelligence company,today provided an update on its VIE\'s ongoing paten
Aug 28, 2024
Strengthened Commercialization across Payments and Digital Commerce Ecosystem Remarkable Overseas Expansion Progress
Aug 28, 2024
SEOUL,South Korea,Aug. 28,2024-- Yunovia,a drug R&D subsidiary of Ildong Pharmaceutical Group,announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has cleared the IND ap
Aug 28, 2024
The exclusive new free-roam VR experience will be available at Zero Latency VR venues globally from September 25,with a bonus gift for eager fans who pre-book.
Aug 28, 2024
RAICHUR,India,Aug. 28,2024-- In a major breakthrough,Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship
Aug 28, 2024

© TopicFashion Privacy Policy Contact us